secwatch.observer — SEC 8-K summary
======================================

Issuer:     JOHNSON & JOHNSON (JNJ)
CIK:        0000200406
Form:       8-K
Filed at:   2026-07-29T21:25:05+00:00
Accession:  0000200406-26-000163
Event type: other_material
Sentiment:  negative
Materiality: 0.85
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

JNJ completes Firefly acquisition, enters Sail collaboration; cuts 2026 EPS guidance by $0.64
--------------------------------------------------------------------------------

- 2026 adjusted operational EPS midpoint lowered to $10.94 from $11.58; adjusted EPS midpoint to $11.04 from $11.68.
- Firefly acquisition reduces 2026 EPS by ~$0.46; Sail collaboration reduces by ~$0.18.
- 2027 adjusted EPS expected to decrease by ~$1.36 ($0.08 Firefly, $1.28 Sail assuming milestones).
- Operational sales guidance maintained at $100.3B-$100.9B; adjusted pre-tax operating margin guidance cut by ~150 bps.
- Transactions include completion of Firefly Bio acquisition and strategic agreements with Sail Biomedicines.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/200406/000020040626000163/0000200406-26-000163-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/200406/000020040626000163/jnj-20260729.htm
  HTML page:      https://secwatch.observer/filing/0000200406-26-000163

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer